A newly formed advisory committee will develop and coordinate a strategic federal research agenda on environmental and genetic factors related to breast cancer. The 19-member Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC) was established by the National Institute of Environmental Health Sciences (NIEHS), in collaboration with the National Cancer Institute (NCI), to review all breast cancer research efforts conducted or supported by federal agencies.

Related posts:

  1. Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
  2. Medicare Health Checkups – Comparing Models that Assess Breast Cancer Risk A new study found that models for assessing breast cancer risk perform only slightly better when they include common inherited genetic variants recently linked to the disease. For now, recommendations for breast cancer screening or treatments that are based on such models will remain unchanged for most women....
  3. Secretary Sebelius Statement on New Breast Cancer Recommendations Secretary Sebelius Statement on New Breast Cancer Recommendations...
  4. Breast Cancer: Rates of New Cases and Deaths Breast Cancer: Rates of New Cases and Deaths ...
  5. Five New Members Named to NIH Advisory Committee on Research on Women’s Health The National Institutes of Health Advisory Committee on Research on Women’s Health announces the appointment of five new members: Francisco Garcia, M.D., M.P.H., Ronda S. Henry-Tillman, M.D., F.A.C.S., Karen E. Kim, M.D., Claire Pomeroy, M.D., and Paul F. Terranova, Ph.D....
  6. Medicare Future? Pathways that Can Repair Brca1 Cancer Gene Mutation Clarified in Mice In a new study in mice, scientists have compensated for mutations in the Brca1 gene that can lead to cancer by deleting a second gene, which then lessens the probability of cancer. Mice Brca1-associated mammary tumors have significant similarities to human BRCA1- associated (BReast CAncer 1, early onset) breast cancer in regard to tumor aggressiveness, high incidence, mutations and genetic instability. The study, led by scientists at National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues, appeared online April 1, 2010 and in print April 16, 2010, in the journal Cell....
  7. The Human Services Committee is giving strong consideration to two measures that would go a long way toward lowering health care costs and improving health care quality. CONNECTICUT: The Human Services Committee is giving strong consideration to two measures that would go a long way toward lowering health care costs and improving health care quality....
  8. The Cancer Genome Atlas completes detailed ovarian cancer analysis An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature. MedicareCard.com […]...
  9. Researchers design a light therapy that targets and destroys cancer cells in mice Researchers have designed a light-based therapy that allows the selective destruction of tumor cells in mice without harming surrounding normal tissue. This method of cancer therapy could theoretically work against tumors in humans, such as those of the breast, lung, prostate, as well as cancer cells in the blood such as leukemias, say scientists from […]...
  10. Panel Calls for Reducing Colorectal Cancer Deaths by Striking Down Barriers to Screening Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical. ...
  11. 2010 National Mammography Day According to healthfinder.gov’s Health Observances page, Oct. 22 is National Mammography Day. On this day, women are encouraged to make an appointment for their annual mammograms. You can take this National Mammography Day Quiz to see how much you know about mammography. We all have busy lives and let’s face it, getting a mammogram can […]...
  12. Lung cancer trial results show mortality benefit with low-dose CT The National Cancer Institute (NCI) is today releasing initial results from a large-scale test of screening methods to reduce deaths from lung cancer by detecting cancers at relatively early stages....
  13. Medicare, Lung cancer trial results show mortality benefit with low-dose CT The National Cancer Institute (NCI) is today releasing initial results from a large-scale test of screening methods to reduce deaths from lung cancer by detecting cancers at relatively early stages....
  14. Medicare, Submit your visionary ideas about environmental health research The National Institute of Environmental Health Sciences (NIEHS) is seeking input from the public as well as researchers for its new strategic plan. To get involved, submit an idea for research or nominate a workshop participant....
  15. Medicare Blog, New Study Implicates Healthcare Utilization Rates, More than Biology, in Colorectal Cancer Disparities Higher rates of colorectal cancer incidence and mortality experienced by African-Americans may be driven largely by differences in health care utilization, and less by biology, according to a new study led by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health....